{"id":"NCT00276094","sponsor":"Shionogi","briefTitle":"A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women","officialTitle":"Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Oral Ospemifene 30 and 60 Mg Daily Doses With Placebo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":null,"completion":"2007-12","firstPosted":"2006-01-12","resultsPosted":"2013-06-28","lastUpdate":"2013-06-28"},"enrollment":826,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Atrophy","Vaginal Diseases"],"interventions":[{"type":"DRUG","name":"Ospemifene 30 mg","otherNames":[]},{"type":"DRUG","name":"Ospemifene 60 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Nonhormonal vaginal lubricant","otherNames":["K-YÂ® Brand Jelly"]}],"arms":[{"label":"Ospemifene 30 mg/day and nonhormonal vaginal lubricant","type":"EXPERIMENTAL"},{"label":"Ospemifene 60 mg/day and nonhormonal vaginal lubricant","type":"EXPERIMENTAL"},{"label":"Placebo tablets and nonhormonal vaginal lubricant","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether ospemifene is more effective than placebo in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.","primaryOutcome":{"measure":"Mean Change From Baseline in the Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) of Vaginal Dryness","timeFrame":"Baseline (Randomization) to Week 12","effectByArm":[{"arm":"Ospemifene 30 mg/Day and Nonhormonal Vaginal Lubricant","deltaMin":-1.22,"sd":0.929},{"arm":"Ospemifene 60 mg/Day and Nonhormonal Vaginal Lubricant","deltaMin":-1.26,"sd":1.025},{"arm":"Placebo Tablets and Nonhormonal Vaginal Lubricant","deltaMin":-0.84,"sd":0.996}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":282},"commonTop":["Hot Flush","Urinary Tract Infection","Headache","Vaginal Discharge","Sinusitis"]}}